These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Epigenetic mechanism of cardiac differentiation of stem cells]. Zhu H; Liu Y; Zhang Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356 [TBL] [Abstract][Full Text] [Related]
6. Epigenetics primer: why the clinician should care about epigenetics. Duarte JD Pharmacotherapy; 2013 Dec; 33(12):1362-8. PubMed ID: 23864439 [TBL] [Abstract][Full Text] [Related]
7. [Epigenetic Effect of Environmental Factors on Neurodevelopmenal Disorders]. Kubota T Nihon Eiseigaku Zasshi; 2016; 71(3):200-207. PubMed ID: 27725423 [TBL] [Abstract][Full Text] [Related]
8. [Acquired disorders and epigenetics]. Ushijima T Gan To Kagaku Ryoho; 2010 Sep; 37(9):1645-9. PubMed ID: 20841925 [TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing in epigenetics: insights and challenges. Meaburn E; Schulz R Semin Cell Dev Biol; 2012 Apr; 23(2):192-9. PubMed ID: 22027613 [TBL] [Abstract][Full Text] [Related]
10. Epigenetics in prostate cancer: biologic and clinical relevance. Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191 [TBL] [Abstract][Full Text] [Related]
11. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. Dobosy JR; Roberts JL; Fu VX; Jarrard DF J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351 [TBL] [Abstract][Full Text] [Related]
12. Epigenetics, copy number variation, and other molecular mechanisms underlying neurodevelopmental disabilities: new insights and diagnostic approaches. Gropman AL; Batshaw ML J Dev Behav Pediatr; 2010 Sep; 31(7):582-91. PubMed ID: 20814257 [TBL] [Abstract][Full Text] [Related]
13. Epigenetics in women's health care. Pozharny Y; Lambertini L; Clunie G; Ferrara L; Lee MJ Mt Sinai J Med; 2010; 77(2):225-35. PubMed ID: 20309920 [TBL] [Abstract][Full Text] [Related]
14. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731 [TBL] [Abstract][Full Text] [Related]
15. Introduction into the analysis of high-throughput-sequencing based epigenome data. Huss M Brief Bioinform; 2010 Sep; 11(5):512-23. PubMed ID: 20457755 [TBL] [Abstract][Full Text] [Related]
16. Interplay between different epigenetic modifications and mechanisms. Murr R Adv Genet; 2010; 70():101-41. PubMed ID: 20920747 [TBL] [Abstract][Full Text] [Related]
18. Understanding the epigenetics of neurodevelopmental disorders and DOHaD. Kubota T; Miyake K; Hariya N; Mochizuki K J Dev Orig Health Dis; 2015 Apr; 6(2):96-104. PubMed ID: 25708304 [TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental disorders with epigenetic dysregulation and Sang Cho K; Song B; Lee IS Front Biosci (Landmark Ed); 2019 Jun; 24(7):1330-1349. PubMed ID: 31136982 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers in prostate cancer: Current and future uses. Chiam K; Ricciardelli C; Bianco-Miotto T Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]